Irene Tan
About Irene Tan
Irene Tan is a Senior Scientist with expertise in Molecular Biology and Biochemistry, currently working at Sangamo Therapeutics, Inc. in Richmond, California. She has a strong academic background with a PhD from Johns Hopkins University and has held various research positions in prominent biotechnology companies.
Work at Sangamo Therapeutics
Irene Tan currently serves as a Senior Scientist at Sangamo Therapeutics, Inc., a biotechnology company based in Richmond, California. She has been in this role since 2023. Prior to her current position, she worked as a Scientist at the same organization from 2020 to 2022. Her work at Sangamo Therapeutics involves applying her expertise in molecular biology and biochemistry to advance scientific projects within the biotechnology sector.
Education and Expertise
Irene Tan holds a PhD in Cell, Molecular, Developmental Biology, and Biophysics from The Johns Hopkins University, which she completed from 2010 to 2015. She also earned a Bachelor of Science in Microbial Biology from the University of California, Berkeley, from 2005 to 2009. Her educational background provides her with a strong foundation in molecular biology, biochemistry, and bacterial genetics, enabling her to contribute effectively to complex scientific projects.
Background
Irene Tan has a diverse professional background in the biotechnology industry. She began her career as a Biology Intern at Gilead Sciences in 2009. Following this, she worked as a Research Associate at The J. David Gladstone Institutes for six months in 2009-2010. She then served as a Postdoctoral Research Fellow at Genentech from 2015 to 2018 and as a Scientist at Zymergen from 2018 to 2020. This varied experience has equipped her with a broad skill set relevant to her current role.
Previous Roles in Biotechnology
Irene Tan has held several significant positions in the biotechnology field. After her internship at Gilead Sciences, she worked as a Research Associate at The J. David Gladstone Institutes for six months. She then transitioned to Genentech, where she was a Postdoctoral Research Fellow for three years. Following her tenure at Genentech, she worked as a Scientist at Zymergen for two years before joining Sangamo Therapeutics. These roles have contributed to her extensive knowledge and expertise in molecular biology and biochemistry.